Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Interest Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Interest Expenses for 2 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 17.91% to $1.9 million in Q4 2025 year-over-year; TTM through Oct 2025 was $7.4 million, a 25.93% increase, with the full-year FY2025 number at $7.7 million, up 24.14% from a year prior.
  • Interest Expenses was $1.9 million for Q4 2025 at Kestra Medical Technologies, down from $1.9 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $2.3 million in Q4 2024 to a low of $1.7 million in Q1 2024.